What is Unlearn?
Digital twins that make clinical trials smaller and faster.
Who is Unlearn best for?
Unlearn is best for pharma and biotech trial teams that want digital twins of participants to run clinical trials with fewer patients.
Trial design before protocol sign-off
It simulates the study against the criteria on the table and compares sample size, eligibility and endpoint options using sourced data from earlier trials.
Smaller control arms
Each participant's digital twin forecasts their likely course without treatment, which lets a trial keep its statistical power with fewer patients.
Single-arm and open-label studies
When a placebo arm is not possible, the digital twins act as an external control group for comparing treatment effects.
Teams after a readout
It re-analyses a completed trial against each participant's twin to separate expected disease progression from the treatment effect and to plan the next study.
How much does Unlearn cost?
Unlearn does not publish prices: it works as a partnership with pharma and biotech sponsors, arranged through a contact form about your study, and the maker states no free plan or trial.
Unlearn has no pricing page or plans. Work is scoped per study, program or portfolio after a sponsor fills in a form saying where the study stands (in design, in progress or after readout) and what it needs to decide, and it includes Unlearn's own scientists working alongside the sponsor's team. Plans and current prices are on unlearn.ai.
How do readers rate Unlearn?
No one has rated Unlearn yet. Be the first.
Sign in to rate. One rating per account.
Questions about Unlearn
What is Unlearn?
Digital twins that make clinical trials smaller and faster.
Who is Unlearn for?
Unlearn is best for pharma and biotech trial teams that want digital twins of participants to run clinical trials with fewer patients.
Is Unlearn free?
No. Unlearn is a paid tool.
Where can I try Unlearn?
On its official website, unlearn.ai.
Do regulators accept Unlearn's digital twin method?
The European Medicines Agency has qualified Unlearn's digital twin method for Phase 2 and 3 randomised trials with continuous outcomes, according to Unlearn, and the US FDA gave positive feedback on using it in covariate-adjusted analyses.
Can Unlearn build models on our own trial data?
Yes. Besides its own disease-specific models, Unlearn lets sponsors build custom digital twin generators on their own data inside their own secure environment, as a web app or on-premises, and it states GxP, 21 CFR Part 11 and SOC 2 Type 2 compliance.
Knowtex
Triomics
Hippocratic AI
Abridge
CompliantChatGPT
Dr.AI